GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Enterprise Value

Abingdon Health (LSE:ABDX) Enterprise Value : £12.63 Mil (As of Jun. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Abingdon Health's Enterprise Value is £12.63 Mil. Abingdon Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-2.30 Mil. Therefore, Abingdon Health's EV-to-EBIT ratio for today is -5.50.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Abingdon Health's Enterprise Value is £12.63 Mil. Abingdon Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £-1.67 Mil. Therefore, Abingdon Health's EV-to-EBITDA ratio for today is -7.58.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Abingdon Health's Enterprise Value is £12.63 Mil. Abingdon Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £5.34 Mil. Therefore, Abingdon Health's EV-to-Revenue ratio for today is 2.36.


Abingdon Health Enterprise Value Historical Data

The historical data trend for Abingdon Health's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Enterprise Value Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Enterprise Value
Get a 7-Day Free Trial - - 43.41 12.27 12.39

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.52 12.27 4.55 12.39 12.40

Competitive Comparison of Abingdon Health's Enterprise Value

For the Diagnostics & Research subindustry, Abingdon Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's Enterprise Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Enterprise Value falls into.



Abingdon Health Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Abingdon Health's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as

Abingdon Health's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health  (LSE:ABDX) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Abingdon Health's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=12.632/-2.295
=-5.50

Abingdon Health's current Enterprise Value is £12.63 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-2.30 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Abingdon Health's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=12.632/-1.667
=-7.58

Abingdon Health's current Enterprise Value is £12.63 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £-1.67 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Abingdon Health's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12.632/5.344
=2.36

Abingdon Health's current Enterprise Value is £12.63 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £5.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health Enterprise Value Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (LSE:ABDX) Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines